Vitrolife AB (VITR) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.021x

Based on the latest financial reports, Vitrolife AB (VITR) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr172.00 Million ≈ $18.51 Million USD) by net assets (Skr8.07 Billion ≈ $868.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See VITR equity financing ratio to measure how much of total assets are equity-financed.

Vitrolife AB - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Vitrolife AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check VITR cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Vitrolife AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vitrolife AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Natural Resource Partners LP
NYSE:NRP
0.052x
Shenzhen Clou Electronics Co Ltd
SHE:002121
0.146x
Beijing Urban Construction Investment & Development Co Ltd
SHG:600266
0.032x
Guizhou Redstar Developing Co Ltd
SHG:600367
0.010x
One Software Technologies Ltd
TA:ONE
0.082x
Xiamen Kingdomway Group Co
SHE:002626
0.040x
Jade Bird Fire Alarm
SHE:002960
-0.011x
RPC Inc
NYSE:RES
0.028x

Annual Cash Flow Conversion Efficiency for Vitrolife AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Vitrolife AB from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Vitrolife AB.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr7.89 Billion
≈ $849.63 Million
Skr635.00 Million
≈ $68.34 Million
0.080x +20.97%
2024-12-31 Skr13.64 Billion
≈ $1.47 Billion
Skr907.00 Million
≈ $97.61 Million
0.066x +11.75%
2023-12-31 Skr12.72 Billion
≈ $1.37 Billion
Skr757.00 Million
≈ $81.47 Million
0.059x +56.60%
2022-12-31 Skr16.74 Billion
≈ $1.80 Billion
Skr636.00 Million
≈ $68.44 Million
0.038x +51.66%
2021-12-31 Skr15.34 Billion
≈ $1.65 Billion
Skr384.31 Million
≈ $41.36 Million
0.025x -85.82%
2020-12-31 Skr2.02 Billion
≈ $217.06 Million
Skr356.45 Million
≈ $38.36 Million
0.177x -23.14%
2019-12-31 Skr1.80 Billion
≈ $193.45 Million
Skr413.33 Million
≈ $44.48 Million
0.230x -1.55%
2018-12-31 Skr1.50 Billion
≈ $161.02 Million
Skr349.44 Million
≈ $37.60 Million
0.234x -8.09%
2017-12-31 Skr1.23 Billion
≈ $132.22 Million
Skr312.19 Million
≈ $33.60 Million
0.254x +43.04%
2016-12-31 Skr1.02 Billion
≈ $109.81 Million
Skr181.26 Million
≈ $19.51 Million
0.178x -22.44%
2015-12-31 Skr844.97 Million
≈ $90.93 Million
Skr193.53 Million
≈ $20.83 Million
0.229x +10.47%
2014-12-31 Skr702.57 Million
≈ $75.61 Million
Skr145.67 Million
≈ $15.68 Million
0.207x -36.98%
2013-12-31 Skr322.60 Million
≈ $34.72 Million
Skr106.13 Million
≈ $11.42 Million
0.329x +53.14%
2012-12-31 Skr278.98 Million
≈ $30.02 Million
Skr59.93 Million
≈ $6.45 Million
0.215x +87.22%
2011-12-31 Skr343.90 Million
≈ $37.01 Million
Skr39.46 Million
≈ $4.25 Million
0.115x -22.63%
2010-12-31 Skr326.33 Million
≈ $35.12 Million
Skr48.40 Million
≈ $5.21 Million
0.148x +11.59%
2009-12-31 Skr312.07 Million
≈ $33.58 Million
Skr41.48 Million
≈ $4.46 Million
0.133x -9.19%
2008-12-31 Skr292.39 Million
≈ $31.47 Million
Skr42.79 Million
≈ $4.61 Million
0.146x +74.23%
2007-12-31 Skr253.38 Million
≈ $27.27 Million
Skr21.29 Million
≈ $2.29 Million
0.084x -22.07%
2006-12-31 Skr220.64 Million
≈ $23.74 Million
Skr23.78 Million
≈ $2.56 Million
0.108x +34.70%
2005-12-31 Skr176.45 Million
≈ $18.99 Million
Skr14.12 Million
≈ $1.52 Million
0.080x -13.96%
2004-12-31 Skr150.57 Million
≈ $16.20 Million
Skr14.01 Million
≈ $1.51 Million
0.093x -57.25%
2003-12-31 Skr143.44 Million
≈ $15.44 Million
Skr31.20 Million
≈ $3.36 Million
0.218x -30.30%
2002-12-31 Skr111.40 Million
≈ $11.99 Million
Skr34.77 Million
≈ $3.74 Million
0.312x --

About Vitrolife AB

ST:VITR Sweden Medical Devices
Market Cap
$1.28 Billion
Skr11.87 Billion SEK
Market Cap Rank
#7764 Global
#117 in Sweden
Share Price
Skr87.65
Change (1 day)
+1.80%
52-Week Range
Skr85.20 - Skr151.10
All Time High
Skr560.50
About

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more